COPD
The proportion of individuals with innate slow mEPHX activity (homozygotes) was significantly higher in both the COPD group and the emphysema group than in the control group (COPD 13 [19%] vs control 13 [6%]; emphysema 21 [22%] vs 13 [6%]).
The proportion of individuals with innate slow <span class="gene" id="9288046-5-47-52">mEPHX</span> activity (homozygotes) was significantly higher in both the <span class="disease" id="9288046-5-113-117">COPD</span> group and the emphysema group than in the control group (COPD 13 [19%] vs control 13 [6%]; emphysema 21 [22%] vs 13 [6%]).